XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts
- Resource Type
- Article
- Authors
- Kamio, Koichiro; Azuma, Arata; Usuki, Jiro; Matsuda, Kuniko; Inomata, Minoru; Nishijima, Nobuhiko; Itakura, Shioto; Hayashi, Hiroki; Kashiwada, Takeru; Kokuho, Nariaki; Atsumi, Kenichiro; Yamaguchi, Tomoyoshi; Fujita, Kazue; Saito, Yoshinobu; Abe, Shinji; Kubota, Kaoru; Gemma, Akihiko
- Source
- In Pulmonary Pharmacology & Therapeutics June 2017 44:61-69
- Subject
- Language
- ISSN
- 1094-5539